Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8391799rdf:typepubmed:Citationlld:pubmed
pubmed-article:8391799lifeskim:mentionsumls-concept:C0023823lld:lifeskim
pubmed-article:8391799lifeskim:mentionsumls-concept:C2717940lld:lifeskim
pubmed-article:8391799lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:8391799lifeskim:mentionsumls-concept:C1158917lld:lifeskim
pubmed-article:8391799pubmed:issue3lld:pubmed
pubmed-article:8391799pubmed:dateCreated1993-8-5lld:pubmed
pubmed-article:8391799pubmed:abstractText25R)-26-Hydroxycholesterol, 25-hydroxycholesterol, and 3 beta-hydroxy-5 alpha-cholest-8(14)-en-15-one, all extraordinarily potent suppressors of sterol synthesis and 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase activity in mammalian cells, have been studied with respect to their effects on the metabolism of low density lipoproteins (LDL) by human hepatocarcinoma (HepG2) cells. The three oxysterols differed markedly in their effects on LDL metabolism, as measured by the combination of cell-associated plus degraded 125I-LDL. The 26-hydroxysterol, at concentrations from 0.1 microM to 75 microM, lowered LDL metabolism. In contrast, the 25-hydroxysterol and the 15-ketosterol, at concentrations from 0.05 microM to 2.5 microM, caused an increase in LDL metabolism. At higher concentrations of these oxysterols, LDL metabolism was suppressed. However, upon increasing the concentration of the 15-ketosterol further to 75 microM, an extraordinary 9-fold increase in LDL metabolism was observed. In contrast to their effects on LDL metabolism, the 25-hydroxysterol and the 15-ketosterol caused simple concentration-dependent decreases in the levels of HMG-CoA reductase activity under the same conditions.lld:pubmed
pubmed-article:8391799pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8391799pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8391799pubmed:languageenglld:pubmed
pubmed-article:8391799pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8391799pubmed:citationSubsetIMlld:pubmed
pubmed-article:8391799pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8391799pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8391799pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8391799pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8391799pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8391799pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8391799pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8391799pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8391799pubmed:statusMEDLINElld:pubmed
pubmed-article:8391799pubmed:monthJunlld:pubmed
pubmed-article:8391799pubmed:issn0006-291Xlld:pubmed
pubmed-article:8391799pubmed:authorpubmed-author:ViaD PDPlld:pubmed
pubmed-article:8391799pubmed:authorpubmed-author:SpilmanC HCHlld:pubmed
pubmed-article:8391799pubmed:authorpubmed-author:SchroepferG...lld:pubmed
pubmed-article:8391799pubmed:authorpubmed-author:PinkertonF...lld:pubmed
pubmed-article:8391799pubmed:issnTypePrintlld:pubmed
pubmed-article:8391799pubmed:day30lld:pubmed
pubmed-article:8391799pubmed:volume193lld:pubmed
pubmed-article:8391799pubmed:ownerNLMlld:pubmed
pubmed-article:8391799pubmed:authorsCompleteYlld:pubmed
pubmed-article:8391799pubmed:pagination1091-7lld:pubmed
pubmed-article:8391799pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:8391799pubmed:meshHeadingpubmed-meshheading:8391799-...lld:pubmed
pubmed-article:8391799pubmed:meshHeadingpubmed-meshheading:8391799-...lld:pubmed
pubmed-article:8391799pubmed:meshHeadingpubmed-meshheading:8391799-...lld:pubmed
pubmed-article:8391799pubmed:meshHeadingpubmed-meshheading:8391799-...lld:pubmed
pubmed-article:8391799pubmed:meshHeadingpubmed-meshheading:8391799-...lld:pubmed
pubmed-article:8391799pubmed:meshHeadingpubmed-meshheading:8391799-...lld:pubmed
pubmed-article:8391799pubmed:meshHeadingpubmed-meshheading:8391799-...lld:pubmed
pubmed-article:8391799pubmed:meshHeadingpubmed-meshheading:8391799-...lld:pubmed
pubmed-article:8391799pubmed:meshHeadingpubmed-meshheading:8391799-...lld:pubmed
pubmed-article:8391799pubmed:meshHeadingpubmed-meshheading:8391799-...lld:pubmed
pubmed-article:8391799pubmed:meshHeadingpubmed-meshheading:8391799-...lld:pubmed
pubmed-article:8391799pubmed:year1993lld:pubmed
pubmed-article:8391799pubmed:articleTitleDiffering effects of three oxysterols on low density lipoprotein metabolism in HepG2 cells.lld:pubmed
pubmed-article:8391799pubmed:affiliationDepartment of Biochemistry and Cell Biology, Rice University, Houston, TX 77251.lld:pubmed
pubmed-article:8391799pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8391799pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:8391799pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:8391799pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed